Autophagic compound database: A resource connecting autophagy-modulating compounds, their potential targets and relevant diseases.

about

Autophagic compound database: A resource connecting autophagy-modulating compounds, their potential targets and relevant diseases.

Item

http://www.wikidata.org/entity/Q47864357

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Autophagic compound database: ...... targets and relevant diseases.

@en

Autophagic compound database: ...... targets and relevant diseases.

@nl

type

Item

label

Autophagic compound database: ...... targets and relevant diseases.

@en

Autophagic compound database: ...... targets and relevant diseases.

@nl

prefLabel

Autophagic compound database: ...... targets and relevant diseases.

@en

Autophagic compound database: ...... targets and relevant diseases.

@nl

P1476

Autophagic compound database: ...... targets and relevant diseases

@en

P2093

Guan Wang

http://www.w3.org/2001/XMLSchema#string

Haoyang Cai

http://www.w3.org/2001/XMLSchema#string

Yiqi Deng

http://www.w3.org/2001/XMLSchema#string

P2860

The Role of Autophagy, Mitophagy and Lysosomal Functions in Modulating Bioenergetics and Survival in the Context of Redox and Proteotoxic Damage: Implications for Neurodegenerative Diseases

Deconvoluting the complexity of autophagy and Parkinson's disease for potential therapeutic purpose

To be or not to be? How selective autophagy and cell death govern cell fate

Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession.

Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo.

Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease.

Berberine attenuates autophagy in adipocytes by targeting BECN1.

Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial.

Combination erlotinib-cisplatin and Atg3-mediated autophagy in erlotinib resistant lung cancer.

Key autophagic targets and relevant small-molecule compounds in cancer therapy.

P304

e12403

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CPR.12403

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bo Liu

Lingjuan Zhu

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29094410

http://www.w3.org/2001/XMLSchema#string

P932

6528906

http://www.w3.org/2001/XMLSchema#string